logo
What are the benefits of mullein tea?

What are the benefits of mullein tea?

Mullein tea may possess many benefits. This can potentially include supporting lung health, and having an antimicrobial effect. However, there is limited evidence supporting this and more research is still necessary.Mullein tea is a beverage that has played a role in traditional medicine for hundreds of years. People have used tea made from the leaves of the common mullein plant (Verbascum thapsus) as a herbal remedy for persistent coughs, asthma, and colds.Mullein refers to a genus of plants, containing over 2,500 species, native to Europe, Asia, and Africa. V. thapsus is a single species of mullein. People worldwide have tried it for its aromatic flavor and potential medicinal properties.Potential benefits and uses of mullein teaMullein tea may offer health benefits, but more research is necessary to demonstrate its potential health benefits in humans. At present, most research involves parts or elements of mullein in test tubes. As such, the possible benefits from these studies may not reflect what happens in humans. Further research could help people understand the effects of mullein on humans.Lung healthA 2021 review notes that people may consume mullein to help relieve respiratory problems, such as colds, coughs, hoarseness, asthma, and bronchitis. This may be due to its potential to relieve coughs and loosen mucus, although researchers are yet to understand how it achieves these effects.Mullein tea's potential effect on respiratory symptoms may be due to the presence of anti-inflammatory plant compounds, including flavonoids, iridoids, glycosides, saponins, vitamin C, and various minerals. This could help with conditions involving inflammation of the airways, such as asthma. However, further research needs to assess the effects of mullein tea in treating asthma and other respiratory conditions, as many studies use a fluid extract or individual chemical components. The concentration of plant compounds that pass from the leaves into the infused beverage remains unclear.Antibacterial propertiesSome test-tube studies suggest that mullein extract can reduce the growth of certain bacteria. For example, a 2020 study found that a common bacterium in soil called Bacillus cereus was most sensitive to the effects of V. thapsus.According to a 2021 review, research has also found the plant fluid extract to be effective against bacteria that cause respiratory infections. However, a more recent study found that while previous authors have identified antibacterial properties in V. thapsus, it showed no effects on Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus).Again, these have studied extracts in test tubes. They do not give a reliable indication of mullein tea's effects on humans.Might have other health effectsAlthough test-tube studies have not directly demonstrated mullein tea's effects on human health, the plant contains multiple compounds that could provide potential health benefits. Aside from potential anti-inflammatory and antibacterial effects, these might include:antiviral action, with some evidence suggesting it may possess potent antiviral activity against some virusesanticancer effects, according to a 2022 study involving alcohol-derived extracts combined with extracts from other plantsprotective effects on brain cells, per a 2022 study on mice who had Alzheimer's diseaseHowever, more research is still necessary to confirm the effects of mullein tea on human health.Possible side effects of mullein teaGenerally, health experts consider mullein tea to be safe with no known side effects.However, tiny hairs sit on the surface of its leaves, and they have natural irritant properties to ward off cattle and other grazing animals. In some individuals, these hairs may trigger a contact dermatitis reaction when handling the plant.A 2019 case report found that a 12-year-old girl experienced contact dermatitis after exposure to a combination of V. thapsus and another plant family called Asteraceae. Although the researchers could not directly link the reaction to V. thapsus alone, they also could not rule it out.No safety data is available to confirm whether mullein tea is safe for consumption during pregnancy or chestfeeding.How to prepare mullein teaMullein is available in various forms, including teabags, extracts, dried leaves, capsules, and tinctures. The packaging will provide instructions for preparing each specific product.The Food and Drug Administration (FDA) regulates supplements and herbal products differently than it does medications. This means that the ingredient lists may be misleading, and the packaging may suggest benefits that evidence does not support.Those who have foraged and dried wild mullein leaves can submerge a handful of leaves in around 8 ounces (oz) of boiling water for thirty minutes or more. For a clump-free tea, place the leaves in a strainer or infuser and remove them after finishing the tea. Adding honey can make it into a cough syrup.SummaryVerbascum thapsus (V. thapsus) is a species of mullein plant that people may use in herbal remedies. Mullein tea is one of the possible preparations that people derive from the plant.Some evidence suggest that mullein may reduce coughing and loosen mucus in people with asthma and other respiratory conditions. It may also reduce bacterial growth and has a range of plant compounds that could have beneficial effects.However, current evidence has only looked at the effects of mullein on cells in tubes or animals. As such, more research is humans is still necessary.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mysterious condition reappears as Trump visits Scotland amid concerns over his chronic diagnosis
Mysterious condition reappears as Trump visits Scotland amid concerns over his chronic diagnosis

Daily Mail​

timean hour ago

  • Daily Mail​

Mysterious condition reappears as Trump visits Scotland amid concerns over his chronic diagnosis

Donald Trump appeared with makeup on his hands again during his trip to Scotland just weeks after the White House explained the president's mysterious bruises. The Daily Mail first reported on Trump's mysterious hand bruising back in February, revealing that Trump's glad-handing had brought on the result. Earlier this month, Trump, 79, appeared at a White House press gaggle with what looked like makeup covering a patch on the back of his hand, sparking concerns. 'This is consistent with minor soft-tissue irritation from frequent handshaking and use of aspirin, which is taken as part of a standard cardiovascular prevention regimen. This is a well-known and benign side effect of aspirin therapy,' White House Press Secretary Karoline Leavitt recently divulged. The president has spent the past few days in Scotland meeting with everyone from UK Prime Minister Keir Starmer to European Commission President Ursula von der Leyen. The makeup covering those bruises has been visible in multiple press photos throughout Trump's trip. Once again, the president appears to be using a lot of concealer to keep the bruise from showing up when he announced a new trade deal with the EU. The makeup appeared to be concealing a raised circular area of skin that Trump's team may have been eager to hide. Earlier this month, in a surprise statement from the podium during a press briefing, White House Press Secretary Karoline Leavitt told reporters the president was checked out by his doctor after noticeable 'swelling' and revealed that Trump has been diagnosed with 'chronic venous insufficiency.' The splotch has been visible on other occasions throughout the past month, sparking a new round of questions about the cause. The makeup appeared to be concealing a raised circular area of skin. Leavitt said during her rare medical update that the president recently ' noticed mild swelling in the lower legs' and 'in keeping with routine medical care and out of the abundance of caution,' he was evaluated by the White House medical unit. He underwent a 'comprehensive examination' which included 'diagnostic vascular studies.' 'Bilateral, lower extremity ultrasounds were performed and revealed chronic venous insufficiency,' Leavitt stated. She said it's a 'common condition' in individuals over the age of 70 and there was 'no evidence' of deep vein thrombosis or arterial disease. 'The president remains in excellent health,' Leavitt said overall. 'Importantly, there was no evidence of deep vein thrombosis or arterial disease,' she added. Leavitt said in response to a question that there was 'no discomfort from the president at all.' She then pointed to his daily activities. 'And you probably all see that on a day-to-day basis, he's working around the clock. As for the treatment, I can defer to the president's physician,' she said. The letter released by White House Physician Sean Barbarella, DO, references 'mild swelling' in Trump's lower legs, and states the diagnosis emerged after a series of vascular studies. Neither Leavitt nor the letter addressed whether Trump would have to modify any of his routines, which include frequent golfing at his private courses on weekends, and his trademark dance moves to 'Y.M.C.A.' when he addresses rally crowds. Leavitt said there was 'no discomfort' for the president at all. Officials have previously mentioned Trump's frequent handshaking – Trump regularly interacts with a large number of people at White House events and when he travels – as the cause of the bruising, but have not previously identified the aspirin issue. The bruising had stayed with Trump from the presidential campaign through his return to the White House. It had even been spotted during Trump's Manhattan court fight in the Stormy Daniels case. According to the Cleveland Clinic, chronic venous insufficiency occurs when leg veins are damaged, making it more difficult for blood to return to the heart. It 'causes blood to pool in your leg veins, leading to high pressure in those veins.' The condition is fairly common, affecting one in 20 adults, and the risk increases with age. It can lead to achy legs, a feeling of 'pins and needles,' cramping, swelling and itching, as well as 'Leathery-looking skin on your legs.' Up to half the people who have had deep vein thrombosis later develop post-thrombotic syndrome within a year or two. That relates to scar tissue that can develop after a blood clot. Trump was the oldest person to take the Oath of Office when he was sworn in in January at age 78. He has said repeatedly that his predecessor Joe Biden, 82, had no idea what he was doing and this week opened a probe into an alleged 'cover-up' through his use of an autopen for a series of commutations. Trump reposted an item in May calling Biden a 'decrepit corpse,' days after Biden got a prostate cancer diagnosis. Trump has made a point of demonstrating his own physical and mental vigor – taking question after question from reporters inside the Oval Office, sometimes speaking for up to an hour.

Prostate cancer checks soar after Sir Chris Hoy reveals diagnosis
Prostate cancer checks soar after Sir Chris Hoy reveals diagnosis

Telegraph

timean hour ago

  • Telegraph

Prostate cancer checks soar after Sir Chris Hoy reveals diagnosis

Thousands more men are having checks for prostate cancer since Sir Chris Hoy revealed he had been diagnosed with the disease and was terminally ill. The six-time Olympic cycling gold medallist was told in 2023 that he was terminally ill with cancer that originated in his prostate, and shared his diagnosis publicly last year. Despite a family history of prostate cancer – which also affected his father and grandfather – Sir Chris was never offered the PSA test that could have detected it. New NHS data show almost 5,000 extra men have been referred for urological cancer in the six months after Sir Chris, 49, spoke out, a trend described by experts as 'staggering'. The figures, from October 2024 to March 2025, show 138,734 men were given an urgent referral for urological cancers, with prostate cancer the main form of disease. This amounts to an extra 4,962 cases compared with the same six-month period in 2023-24. Separate data show a huge increase in the number of men with a family history of prostate cancer who have assessed their own risk. The number of men with such a history who have used an online risk checker to assess their chances of the disease rose by 77 per cent over the period. Telegraph launches screening campaign The findings have been released as The Telegraph launches a campaign calling for the introduction of targeted screening for prostate cancer. Men are not offered tests currently, even if they have a family history of the disease. Experts believe there is a growing case for targeted screening, meaning that PSA blood tests would be offered to those at heightened risk of the disease. Peter Kyle, the Science Secretary, hopes to harness AI and data to improve prostate cancer screening for high-risk men which factors in family history, genetics, demographics and other factors. Mr Kyle, writing in The Telegraph, said he hopes researchers can harness the vast amount of health data available to 'develop AI-powered tools that can predict cancer risk' to save thousands of lives a year. The UK National Screening Committee is currently considering whether to recommend the introduction of mass testing. 'I told my story to raise awareness' Sir Chris said: 'I was diagnosed with stage four prostate cancer at 47. By this age, my prostate cancer was advanced and could have been progressing from when I was 45 or even younger. With prostate cancer, the earlier you find it, the easier it is to treat. We need the system to change to enable more men to get diagnosed earlier, and stop them getting the news I got. 'That's why I believe men at highest risk, for example men with a family history like me, or black men, should be contacted by their GP earlier on to discuss a simple PSA blood test that can check for signs of prostate cancer. 'Then if there are any issues, they can get it treated it at an earlier stage. 'I've told my story to help raise awareness about the most common cancer in men and get more thinking about their risk and what they can do, but it shouldn't all be men's responsibility.' The online risk checking tool, published by Prostate Cancer Research UK, asks men simple questions about their family history and ethnicity to determine risk levels, and gives advice about what help to seek. The charity found that the number of men undergoing the check rose by 45 per cent overall, when data from October 2024 to February 2025 was compared with the same period the year before. The sharpest increase by far came from men aged between 45 and 49, with a family history of the disease. In total 10,427 such men checked their risk, compared with 5,891 in the same period the previous years. In total there were 688,796 checks during the period, up from 473, 843 the year before.

Lesotho mothers fear passing HIV to their babies as US aid cuts halt testing
Lesotho mothers fear passing HIV to their babies as US aid cuts halt testing

Telegraph

timean hour ago

  • Telegraph

Lesotho mothers fear passing HIV to their babies as US aid cuts halt testing

When the young mother-to-be arrived for the test to tell if she was HIV positive and therefore might infect her unborn child, she found the door to the clinic testing room locked. The tests had been halted Mareabetsoe Monyamane, 26, was told, and the counsellors who had once given peace of mind to expectant mothers had been laid off. 'My heart sank,' she told the Telegraph. 'I felt helpless. I sat there thinking about my baby – what if I had contracted HIV since the last test?' For nearly two decades in Lesotho, making sure that women do not pass on HIV to their children has been a cornerstone of the tiny Southern African kingdom's campaign against Aids. If women do test positive, the unborn child can still be protected by prescribing antiretroviral drugs, or anti-HIV protective medicine called pre-exposure prophylaxis, or PrEP. But the programme had been paid for with American aid, which until recently underwrote nearly every level of Lesotho's HIV response. The Prevention of Mother-to-Child Transmission (PMTCT) programme has now become a casualty of Donald Trump's decision to sharply cut back the US President's Emergency Fund for Aids Relief (Pepfar). In a country that has the world's second-highest HIV prevalence, according to the World Health Organization's August 2023 Disease Outlook report, this is devastating for pregnant women like Ms Monyamane. Over 800 of the 1,500 HIV counsellors and nurses who once guided women through testing and helped them protect themselves and their babies have been dismissed as casualties of the aid freeze. The moment she was told she would not be tested 'hit me like cold water,' Ms Monyamane recalled. 'I wanted to cry. Some of us even thought of buying self-test kits, but I am one of those who could not afford it. 'I worry even more – not just about the money to buy the test, but what the results might be and what that would mean for my unborn child. I fear for my baby's life.' Mamello Nchela, aged only 18, says she is terrified of not taking an HIV test. She said: 'The fear of not knowing leaves me with so many what ifs? I keep asking myself: 'What if I'm too late? What if I can't protect my baby?'' Some 19 per cent of people in Lesotho have HIV and their plight led Prince Harry, the Duke of Sussex, to found his charity Sentebale, to help. Unfortunately, Harry and other founders of the charity stepped down earlier this year following a clash with the charity's chief executive. At £54m ($72m) per year, Pepfar accounted for 67 percent of the £78m ($106m) HIV budget for 2024/25, according to Lesotho's ministry of health. The US has now agreed to continue only 28 percent of the Pepfar funding, which will be narrowly focused mainly around medicine distribution. The PMTCT programme has not been spared. In a health centre built with American money but now without American support, eight pregnant women, aged between 17 and 33, sit inside a yellow-walled room where the cold winter air battles the warmth of a small black-and-red paraffin heater. They have come for their monthly check-up and health talk with midwife Mphonyane Thetso, who helplessly watches as drama unfolds before her. 'We have records showing that some women delivered their babies in April and May 2025 with invalid (inconclusive) HIV status because they were not retested after we lost our HIV counsellor,' Ms Thetso said. She explained: 'Sometimes a pregnant woman tests HIV-negative at her first visit. Then, when she comes back at 36 weeks for a re-test, she tests HIV-positive. A woman can give birth HIV-positive without knowing it, if she wasn't retested. 'If she tests positive, we can still prevent mother-to-child transmission with antiretroviral therapy and PrEP 'But you can't give PrEP to someone if you don't know their HIV status.' The concern is shared at the highest levels of Lesotho's health system. The ministry of health's HIV/Aids manager, Dr Tapiwa Tarumbiswa, told parliament in May that 'HIV-unsuppressed mothers are more likely to infect their children during pregnancy, birth, and breastfeeding'. There is little hope in Lesotho that the American aid will be switched back on. Dr Tlohang Letsie, a senior lecturer at the National University of Lesotho said the country lacked minerals that the US can benefit directly from. He said: 'Another factor is that Lesotho seems to be hopeless in engaging the US. The country is simply not doing enough. It appears we are waiting for the divine intervention to blow some spirit of philanthropy into the Americans.' Maitumeleng Tsiame, aged 17, spent £1.70 ($2.30) on a ticket from Metolong, Thaba-Bosiu to Nazareth Health Centre to take her HIV test. When she arrived there, she was told instead to travel to St Joseph Hospital in Roma, requiring another £2.95 ($4) for transport. She said: 'I didn't go to Roma – not because I didn't care – but because I simply couldn't afford it. Deep inside, I am tormented by fear. I keep imagining my child being born with HIV because I couldn't get tested. It hurts. I cry in silence.' Nineteen-year-old Itumeleng Thamae was also turned away from the health centre, saying it was one of the scariest days of her life. She said: 'I felt like my baby's life was at risk, and I couldn't do anything about it. I was overwhelmed by fear – every day I worry if I am unknowingly putting my child in danger.' Matebello Khoahli's children are proof that Lesotho's PMTCT programme used to be effective. The 40-year-old tested HIV-positive in 2009, but two of her three children, aged 12 and five, have been medically declared HIV-negative. But she is now worried about her 23-month-old baby, who missed her final HIV test aged 18 months, in April. She said: 'I was told the office was closed because Trump cut foreign aid to Lesotho, and the people who worked there are no longer around. 'My mind was troubled when I was told my daughter couldn't be tested. Even today, I am still troubled, wondering where I can go for help so my daughter can get her last HIV test,' she said, adding: 'when I asked at the Nazareth Health Centre, they told me to go to St Joseph's Hospital in Roma.' But Khoahli never made the trip. She did not have the £1.90 ($2.60) needed for transport. 'We are in darkness,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store